Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Sexual stimulation

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    68 result(s) found for: Sexual stimulation. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2007-000013-10 Sponsor Protocol Number: PR3042 Start Date*: 2007-03-14
    Sponsor Name:Pantarhei Bioscience B.V.
    Full Title: A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual arousability and the...
    Medical condition: Sexual dysfunction caused by the use of oral contraceptives
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057671 Female sexual dysfunction LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-002770-23 Sponsor Protocol Number: EB91 Start Date*: 2011-07-04
    Sponsor Name:Emotional Brain BV
    Full Title: A double-blind, randomized, placebo-controlled, proof of concept study to investigate the safety and efficacy of the combined administration of 0.5 mg sublingual testosterone and 10 mg tadalafil in...
    Medical condition: Hypoactive Sexual Desire Disorder
    Disease: Version SOC Term Classification Code Term Level
    13.1 10037175 - Psychiatric disorders 10059272 Sexual desire decreased LLT
    13.1 10037175 - Psychiatric disorders 10020933 Hypoactive sexual desire disorder LLT
    13.1 10037175 - Psychiatric disorders 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    13.1 10037175 - Psychiatric disorders 10040465 Sexual arousal decreased LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019540-39 Sponsor Protocol Number: EB80 Start Date*: 2010-05-12
    Sponsor Name:Emotional Brain
    Full Title: A double blind, randomized, cross-over placebo controlled study to investigate the efficacy of sublingual testosterone solution on physiological and subjective arousal in healthy, sexually dysfunct...
    Medical condition: This pharmacodynamic trial will be conducted in sexually dysfunctional otherwise healthy women, but it is a part of a developmental program for medicine for Hypoactive Sexual Desire Disorder (comor...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10040466 Sexual arousal disorders HLT
    12.1 10040470 Sexual desire disorders HLT
    12.1 10040478 Sexual dysfunction NEC HLT
    12.1 10020933 Hypoactive sexual desire disorder LLT
    12.1 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    12.1 10059272 Sexual desire decreased LLT
    12.1 10040465 Sexual arousal decreased LLT
    12.1 10058929 Disturbance in sexual arousal LLT
    12.1 10062641 Female sexual arousal disorder LLT
    12.1 10058929 Disturbance in sexual arousal PT
    12.1 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019285-86 Sponsor Protocol Number: EB79 Start Date*: 2010-05-07
    Sponsor Name:Emotional Brain
    Full Title: A single blind, randomized, cross-over placebo controlled dose finding study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiologi...
    Medical condition: This pharmacokinetic trial will be conducted in healthy women, but it is a part of a developmental program for medicine for Hypoactive Sexual Desire Disorder (comorbidity with other sexual dysfunct...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10040466 Sexual arousal disorders HLT
    12.1 10040470 Sexual desire disorders HLT
    12.1 10040478 Sexual dysfunction NEC HLT
    12.1 10020933 Hypoactive sexual desire disorder LLT
    12.1 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    12.1 10059272 Sexual desire decreased LLT
    12.1 10040465 Sexual arousal decreased LLT
    12.1 10058929 Disturbance in sexual arousal LLT
    12.1 10062641 Female sexual arousal disorder LLT
    12.1 10058929 Disturbance in sexual arousal PT
    12.1 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003543-30 Sponsor Protocol Number: EB93 Start Date*: 2012-08-24
    Sponsor Name:Emotional Brain BV
    Full Title: A double-blind, randomized, placebo-controlled, proof of concept study to investigate the differences between the combined administration of 0.5 mg sublingual testosterone and 10 mg buspirone and 1...
    Medical condition: Hypoactive Sexual Desire Disorder Sexual Interest/Arousal Disorder
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    14.1 10037175 - Psychiatric disorders 10059272 Sexual desire decreased LLT
    14.1 10037175 - Psychiatric disorders 10040465 Sexual arousal decreased LLT
    14.1 10037175 - Psychiatric disorders 10058929 Disturbance in sexual arousal PT
    14.1 10037175 - Psychiatric disorders 10040470 Sexual desire disorders HLT
    14.1 10037175 - Psychiatric disorders 10040466 Sexual arousal disorders HLT
    14.1 10037175 - Psychiatric disorders 10020933 Hypoactive sexual desire disorder LLT
    14.1 10038604 - Reproductive system and breast disorders 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010549-30 Sponsor Protocol Number: 44/09 Start Date*: 2009-12-16
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: PRAMIPEXOLE IN THE MALE LIBIDO FAILURE : A PHASE II, off-label, pilot study
    Medical condition: male libido failure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024419 PT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-002161-56 Sponsor Protocol Number: NeM-CSM-FT-01 Start Date*: 2017-04-13
    Sponsor Name:Mateusz Gola
    Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy
    Medical condition: compulsive sexual behavior (hypersexual disorder)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2022-003857-78 Sponsor Protocol Number: D-CN-52014-244 Start Date*: 2023-06-29
    Sponsor Name:Ipsen Pharma
    Full Title: A phase III, open-label, multicentre, single arm study to assess the efficacy and safety of the triptorelin 6-month formulation in Chinese paediatric participants with central precocious puberty
    Medical condition: Central Precocious Puberty
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2007-000032-68 Sponsor Protocol Number: 511.77 Start Date*: Information not available in EudraCT
    Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG
    Full Title: A Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy trial of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in premenopausal European Women With Hypoacti...
    Medical condition: Primary generalized acquired Hypoactive Sexual Desire Disorder in Premenopausal women
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020933 Hypoactive sexual desire disorder LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) FR (Completed) NL (Completed) BE (Completed) ES (Completed) SE (Completed) HU (Completed) FI (Completed) CZ (Completed) AT (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-001378-19 Sponsor Protocol Number: A5031003 Start Date*: 2004-09-28
    Sponsor Name:Pfizer AB
    Full Title: A two part study to a) investigate the reproducilibility of the vaginal photoplethysmograhpy (VPP) teqnique in healthy pre-menopausal volunteers and subjects suffering from Female Sexual Arousal Di...
    Medical condition: Female Sexual Arousal Disorder (FSAD)
    Disease: Version SOC Term Classification Code Term Level
    10062641
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001835-35 Sponsor Protocol Number: 2014.TTRANSPORT Start Date*: 2015-03-30
    Sponsor Name:Fundación Santiago Dexeus Font (Dexeus)
    Full Title: Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial.
    Medical condition: Infertility in women with poor ovarian response to stimulation for IVF/ICSI
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) ES (Prematurely Ended) DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006957-29 Sponsor Protocol Number: DUBAR01 Start Date*: 2007-08-02
    Sponsor Name:Department of Psychiatry and Psychotherapy, Friedrich-Schiller-University Jena
    Full Title: Influence of Duloxetin on C-fiber function and perception of deep somatic pain in major depression
    Medical condition: We aim to achieve a study population of 30 patients (male or female, 18 to 65 years of age) suffering from major depressive disorder (DSM IV criteria). Depressive symptoms should be present for at ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-001607-30 Sponsor Protocol Number: Debio8206-CPP-301 Start Date*: 2015-04-24
    Sponsor Name:Debiopharm International, S.A.
    Full Title: An open-label, non-comparative, multicenter study on the efficacy, safety, and pharmacokinetics of triptorelin pamoate (embonate) 22.5 mg 6-month formulation in patients suffering from central (gon...
    Medical condition: Central Precocious Puberty
    Disease: Version SOC Term Classification Code Term Level
    18.0 10014698 - Endocrine disorders 10058084 Precocious puberty PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2022-002963-31 Sponsor Protocol Number: D-CN-52014-243 Start Date*: 2023-01-13
    Sponsor Name:Ipsen Pharma
    Full Title: AN OPEN-LABEL, MULTICENTRE, SINGLE-ARM STUDY TO ASSESS THE EFFICACY AND SAFETY OF TRIPTORELIN 3-MONTH FORMULATION IN CHINESE CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY
    Medical condition: Central Precocious Puberty
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2007-005786-35 Sponsor Protocol Number: DC02RUP/IV/02 Start Date*: Information not available in EudraCT
    Sponsor Name:Uriach Pharma
    Full Title: Proof-of-concept, cross over, double blind, placebo-controlled study to assess if Rupatadine 20 mg can improve critical stimulation time thresholds (CSTTs) in patients with acquired cold urticaria
    Medical condition: Acquired Cold Urticaria
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009869 Cold urticaria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-009936-56 Sponsor Protocol Number: ACT10775 Start Date*: 2009-05-11
    Sponsor Name:sanofi-aventis recherche et développement
    Full Title: Randomized, double-blind, placebo and active controlled study of the activity of SAR407899A single-dose on the ability to increase duration of penile rigidity, under experimental condition, in pati...
    Medical condition: Mild to moderate erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    11.1 10061461 LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-001998-15 Sponsor Protocol Number: TRIB–01–08 Start Date*: 2010-08-30
    Sponsor Name:SOPHARMA PLC
    Full Title: A phase IV, 16 weeks, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to assess the efficacy and safety of oral Tribulus terrestris (Tribestan®) in men with erectile dysfun...
    Medical condition: This Phase IV, 16 weeks study will be multicenter, randomized, double-blind, placebo-controlled. It will evaluate the efficacy and safety of Tribestan compared to placebo in men with erectile dysfu...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    14.1 10037175 - Psychiatric disorders 10024419 Libido decreased PT
    Population Age: Adults Gender: Male
    Trial protocol: BG (Completed)
    Trial results: View results
    EudraCT Number: 2009-011411-21 Sponsor Protocol Number: BVF-324-302 Start Date*: 2009-07-17
    Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd
    Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-005571-89 Sponsor Protocol Number: FM53 Start Date*: 2015-06-22
    Sponsor Name:Futura Medical Developments Ltd.
    Full Title: A randomized, double-blind, placebo-controlled, home use, cross-over clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of Erectile Dysfunction
    Medical condition: This study investigates a drug intended for the treatment of male patients self-diagnosed with Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2004-001379-20 Sponsor Protocol Number: A5031004 Start Date*: 2004-09-28
    Sponsor Name:Pfizer AB
    Full Title: A two part study to a) investigate the reproducibility of the vaginal photoplethysmography (VPP) technique in healthy post-menopausal volunteers and subjects suffering from Female Sexual Arousal Di...
    Medical condition: Female Sexual Arousal Disorder (FSAD)
    Disease: Version SOC Term Classification Code Term Level
    10062641
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 02 14:28:28 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA